Literature DB >> 1818766

1-Hydroxyethylidene-1,1-bisphosphonate decreases the postovariectomy enhanced interleukin 1 secretion from peritoneal macrophages in adult rats.

T Matsuda1, K Matsui, Y Shimakoshi, Y Aida, S Hukuda.   

Abstract

Bisphosphonates are potent inhibitors of bone resorption. In previous studies, we have shown that ovariectomy accelerates bone resorption and 1-hydroxyethylidene-1, 1-bisphosphonate (HEBP) inhibits ovariectomy-accelerated bone resorption in female Wistar adult rats. As interleukin 1 (IL-1) stimulates bone resorption in vitro and in vivo, we have investigated the effects of ovariectomy and HEBP administered in vivo on IL-1 secretion from peritoneal macrophages in adult rats. Ovariectomy or sham surgery were performed in female Wistar rats at 40 weeks of age. Ovariectomized and sham-operated rats were administered with HEBP (10 mg) or saline, 10 times in total, from 43 to 46 weeks of age. Paraffin oil-induced peritoneal macrophages at 46 weeks of age were cultured for 24 hours. Lipopolysaccharide (LPS)-stimulated peritoneal macrophages from ovariectomized rats secreted more IL-1 than sham-operated rats. HEBP decreased LPS-stimulated IL-1 secretion from peritoneal macrophages in ovariectomized rats, but not in sham-operated rats. In vivo administration of HEBP decreased IL-1 secretion only in postovariectomy hyperresorptive states. These results suggest that alterations in LPS-stimulated IL-1 secretion from oil-induced peritoneal macrophages may be responsible, at least in part, for the postovariectomy acceleration in bone resorption and its inhibition by HEBP.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1818766     DOI: 10.1007/BF02555851

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  24 in total

1.  Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro.

Authors:  A Carano; S L Teitelbaum; J D Konsek; P H Schlesinger; H C Blair
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

2.  Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy.

Authors:  M Sato; W Grasser
Journal:  J Bone Miner Res       Date:  1990-01       Impact factor: 6.741

3.  Effects of interleukin-1 on bone turnover in normal mice.

Authors:  B F Boyce; T B Aufdemorte; I R Garrett; A J Yates; G R Mundy
Journal:  Endocrinology       Date:  1989-09       Impact factor: 4.736

4.  Migration and phenotypic transformation of osteoclast precursors into mature osteoclasts: the effect of a bisphosphonate.

Authors:  C W Löwik; G van der Pluijm; L J van der Wee-Pals; H B van Treslong-De Groot; O L Bijvoet
Journal:  J Bone Miner Res       Date:  1988-04       Impact factor: 6.741

5.  The influence of pyrophosphate, condensed phosphates, phosphonates and other phosphate compounds on the dissolution of hydroxyapatite in vitro and on bone resorption induced by parathyroid hormone in tissue culture and in thyroparathyroidectomised rats.

Authors:  R G Russell; R C Mühlbauer; S Bisaz; D A Williams; H Fleisch
Journal:  Calcif Tissue Res       Date:  1970

6.  Transforming growth factor type beta induces monocyte chemotaxis and growth factor production.

Authors:  S M Wahl; D A Hunt; L M Wakefield; N McCartney-Francis; L M Wahl; A B Roberts; M B Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

7.  Effect of bisphosphonates on production of interleukin 1-like activity by macrophages and its effect on rabbit chondrocytes.

Authors:  V Evêquoz; U Trechsel; H Fleisch
Journal:  Bone       Date:  1985       Impact factor: 4.398

8.  Endocrine and pharmacological suppressors of bone turnover protect against osteopenia in ovariectomized rats.

Authors:  T J Wronski; L M Dann; K S Scott; L R Crooke
Journal:  Endocrinology       Date:  1989-08       Impact factor: 4.736

9.  An interleukin 1 like factor stimulates bone resorption in vitro.

Authors:  M Gowen; D D Wood; E J Ihrie; M K McGuire; R G Russell
Journal:  Nature       Date:  1983 Nov 24-30       Impact factor: 49.962

10.  Diphosphonates inhibit bone resorption by macrophages in vitro.

Authors:  T J Chambers
Journal:  J Pathol       Date:  1980-11       Impact factor: 7.996

View more
  6 in total

1.  Genetics of the bone response to bisphosphonate treatments.

Authors:  Francesco Massart; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2009-01

2.  Is there a causal role for IL-1 in postmenopausal bone loss?

Authors:  R Pacifici
Journal:  Calcif Tissue Int       Date:  1992-04       Impact factor: 4.333

3.  Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats.

Authors:  R B Kimble; J L Vannice; D C Bloedow; R C Thompson; W Hopfer; V T Kung; C Brownfield; R Pacifici
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

4.  Ovariectomy enhances and estrogen replacement inhibits the activity of bone marrow factors that stimulate prostaglandin production in cultured mouse calvariae.

Authors:  H Kawaguchi; C C Pilbeam; S J Vargas; E E Morse; J A Lorenzo; L G Raisz
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

5.  Interleukin-1 receptor antagonist inhibits calcium accumulation in in vivo chronic granuloma induced by potassium permanganate.

Authors:  P Conti; M Reale; M R Panara; S Fridas; F C Placido; R C Barbacane
Journal:  Calcif Tissue Int       Date:  1993-04       Impact factor: 4.333

6.  Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice.

Authors:  R Kitazawa; R B Kimble; J L Vannice; V T Kung; R Pacifici
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.